Related Experiment Videos
Vasculitis affecting the kidney: presentation, histopathology and long-term outcome
The Quarterly Journal of Medicine
|January 1, 1984
Summary
This study reviewed kidney vasculitis patients, finding poor prognosis and limited treatment efficacy. Microscopic polyarteritis showed extrarenal symptoms and poor outcomes, with oligoanuria and crescents indicating adverse signs.
Area of Science:
- Nephrology
- Pathology
- Immunology
Background:
- Kidney vasculitis, excluding lupus and Schönlein-Henoch purpura, presents diagnostic and prognostic challenges.
- Microscopic polyarteritis, characterized by segmental necrotizing glomerulitis, is a key manifestation of kidney vasculitis.
- Understanding the clinical and histological spectrum is crucial for managing this severe renal disease.
Purpose of the Study:
- To review clinical and histological features of kidney vasculitis.
- To compare outcomes of vasculitis confined to glomerular capillaries versus those with extra-glomerular lesions.
- To assess prognostic factors and treatment efficacy in patients with kidney vasculitis.
Main Methods:
- Retrospective review of 53 patients diagnosed with kidney vasculitis.
- Exclusion of patients with systemic lupus erythematosus or Schönlein-Henoch purpura.
- Clinical assessment, histological examination (including immunohistochemistry and electron microscopy), and survival analysis.
Main Results:
- Clinical presentation was predominantly extrarenal; renal-only presentation occurred in only two patients.
- Segmental necrotizing glomerulitis ('microscopic polyarteritis') was the most common histological finding (42 patients).
- Poor prognosis observed, with 35 deaths and 1-year, 5-year, and 10-year survival rates of 54%, 38%, and 34% respectively. Oligoanuria and extensive crescent formation were adverse prognostic indicators.
Conclusions:
- Kidney vasculitis, particularly microscopic polyarteritis, has a poor prognosis with high mortality.
- Extrarenal manifestations are common, and renal disease progression can be rapid.
- Current treatment strategies show limited efficacy, necessitating further research into effective therapies.